These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 22607938

  • 21. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E, Yaylali V, Cetin EN, Yildirim C.
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [Abstract] [Full Text] [Related]

  • 22. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
    Narayanan S, Miller WL, McDermott AM.
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
    [Abstract] [Full Text] [Related]

  • 23. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M, Calder VL, Buckley RJ, Lightman S.
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [Abstract] [Full Text] [Related]

  • 24. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial.
    Chen M, Gong L, Sun X, Xie H, Zhang Y, Zou L, Qu J, Li Y, He J.
    J Ocul Pharmacol Ther; 2010 Aug; 26(4):361-6. PubMed ID: 20698799
    [Abstract] [Full Text] [Related]

  • 25. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q.
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [Abstract] [Full Text] [Related]

  • 26. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
    Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC.
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
    [Abstract] [Full Text] [Related]

  • 27. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA, Goto E, Tseng SC.
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [Abstract] [Full Text] [Related]

  • 28. Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models.
    Versura P, Profazio V, Schiavi C, Campos EC.
    Invest Ophthalmol Vis Sci; 2011 Jul 25; 52(8):5488-96. PubMed ID: 21498621
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.
    Papp KA, Menter A, Strober B, Langley RG, Buonanno M, Wolk R, Gupta P, Krishnaswami S, Tan H, Harness JA.
    Br J Dermatol; 2012 Sep 25; 167(3):668-77. PubMed ID: 22924949
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye.
    Qu M, Qi X, Wang Q, Wan L, Li J, Li W, Li Y, Zhou Q.
    Invest Ophthalmol Vis Sci; 2019 Sep 03; 60(12):3776-3785. PubMed ID: 31503282
    [Abstract] [Full Text] [Related]

  • 32. Correlation Between the Inflammatory Marker HLA-DR and Signs and Symptoms in Moderate to Severe Dry Eye Disease.
    Brignole-Baudouin F, Riancho L, Ismail D, Deniaud M, Amrane M, Baudouin C.
    Invest Ophthalmol Vis Sci; 2017 Apr 01; 58(4):2438-2448. PubMed ID: 28448672
    [Abstract] [Full Text] [Related]

  • 33. A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction.
    Prabhasawat P, Tesavibul N, Mahawong W.
    Cornea; 2012 Dec 01; 31(12):1386-93. PubMed ID: 23135530
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K, Diquafosol Ophthalmic Solution Phase 2 Study Group.
    Ophthalmology; 2012 Oct 01; 119(10):1954-60. PubMed ID: 22739038
    [Abstract] [Full Text] [Related]

  • 35. Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction.
    Lee H, Min K, Kim EK, Kim TI.
    Am J Ophthalmol; 2012 Dec 01; 154(6):949-957.e1. PubMed ID: 22967863
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease.
    Hardten DR, Brown MJ, Pham-Vang S.
    Curr Med Res Opin; 2007 Sep 01; 23(9):2083-91. PubMed ID: 17822610
    [Abstract] [Full Text] [Related]

  • 37. Analysis of inflammatory cytokines in the tears of dry eye patients.
    Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA.
    Cornea; 2009 Oct 01; 28(9):1023-7. PubMed ID: 19724208
    [Abstract] [Full Text] [Related]

  • 38. Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye.
    Nichols JJ, Bickle KM, Zink RC, Schiewe MD, Haque RM, Nichols KK.
    Eye Contact Lens; 2012 Mar 01; 38(2):73-9. PubMed ID: 22157392
    [Abstract] [Full Text] [Related]

  • 39. [HLA-DR antigen expression on conjunctival epithelial cells in patients with dry eye].
    Mrugacz M, Zywalewska N.
    Klin Oczna; 2005 Mar 01; 107(4-6):278-9. PubMed ID: 16118938
    [Abstract] [Full Text] [Related]

  • 40. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
    Roberts CW, Carniglia PE, Brazzo BG.
    Cornea; 2007 Aug 01; 26(7):805-9. PubMed ID: 17667613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.